Cargando…

Novel Approach for Glycemic Management Incorporating Vibration Stimulation of Skeletal Muscle in Obesity

Because obesity is associated with impaired glucose tolerance and type 2 diabetes (T2D), it is important to manage the blood glucose level at an early stage. Nevertheless, people with obesity have significantly lower resistance to muscle fatigue after exercise and exercise adherence. Therefore, we d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mijin, Zhang, Hanlin, Kim, Taeho, Mori, Yutaro, Okura, Tomohiro, Tanaka, Kiyoji, Isobe, Tomonori, Sakae, Takeji, Oh, Sechang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048751/
https://www.ncbi.nlm.nih.gov/pubmed/36981616
http://dx.doi.org/10.3390/ijerph20064708
Descripción
Sumario:Because obesity is associated with impaired glucose tolerance and type 2 diabetes (T2D), it is important to manage the blood glucose level at an early stage. Nevertheless, people with obesity have significantly lower resistance to muscle fatigue after exercise and exercise adherence. Therefore, we developed a novel “Relaxing-Vibration Training ((R)VT)” consisting of 25 postures using vibration stimulation of skeletal muscle and determined the feasibility of (R)VT for glycemic management. Thirty-one participants with obesity were enrolled in a controlled trial (CT) and experimental trial (ET) based on a 75 g oral glucose tolerance test (OGTT). During the CT, participants were required to rest in a quiet room. During the ET, the (R)VT program (50 Hz, 4 mm), consisting of 25 postures of relaxation and stretching on the vibratory platform, was performed for 40 min. Subsequently, the participants rested as in the CT. Subjective fatigue and muscle stiffness measurements and blood collection were conducted before and after (R)VT. In both the CT and ET, interstitial fluid (ISF) glucose concentrations were measured every 15 min for 2 h. The incremental area under the curve value of real-time ISF glucose during an OGTT was significantly lower in the ET than in the CT (ET: 7476.5 ± 2974.9, CT: 8078.5 ± 3077.7, effect size r = 0.4). Additionally, the levels of metabolic glucose regulators associated with myokines, muscle stiffness, and subjective fatigue significantly improved after (R)VT. This novel (R)VT suggests that it is effective in glycemic management with great potential to improve impaired glucose tolerance and T2D with obesity in the future.